Company / CapEx per Share
Corvus Pharmaceuticals, Inc. CapEx per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2023
5-year range
$0.00 / $0.01
FY2019-FY2023
Trend
-87.7%
vs FY2022
Sector context
#172 of 190
Health Care
What the data says
Among 190 Health Care companies, Corvus Pharmaceuticals, Inc. is in the bottom 9% for capex per share. CapEx per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2021 to $4.68 in FY2015.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -44.0%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -35.0%
- 5-Year CAGR
- -44.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 190This company $0.00 Sector average $2.49
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2023, capex per share decreased 87.7% year-over-year.
- Ranks #172 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2015.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.00 | -87.7% |
| FY2022 | $0.01 | +4736.9% |
| FY2021 | $0.00 | -95.4% |
| FY2020 | $0.00 | +202.7% |
| FY2019 | $0.00 | -93.4% |
| FY2018 | $0.01 | -0.6% |
| FY2017 | $0.01 | -90.9% |
| FY2016 | $0.14 | -97.0% |
| FY2015 | $4.68 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026